“We respect Parth Joshi’s decision to start his entrepreneurial journey,” a BharatPe spokesperson confirmed. At BharatPe, we ...

BharatPe CMO Parth Joshi has resigned and is serving his notice period to launch his own venture. The company confirmed his ...

Takeda CEO Christophe Weber announced he will step down in 2026 and be replaced by Julie Kim, president of Takeda’s U.S.

The company is hoping ... (elranatamab). On GSK's third-quarter results call, chief commercial officer Luke Miels said there is an "increasing respect for the profile of the product," as well ...

One exchange-traded fund that might be attractive for investors worried about U.S. market concentration and volatility is the Franklin International Low Volatility High Dividend Index ETF LVHI, which ...

In the midst of that, Hanon left GSK in April after 20 years at the company, including seven as ... Meanwhile it is also bringing some other high-profile new vaccines through late-stage ...

The Marketing Association of Pakistan (MAP) has announced its newly elected office bearers and council members, as per a press release. Muhammad Azfar Ahsan, Founder & Chairman, Nutshell Group, has ...

Imsidolimab inhibits the function of the IL-36R, compensating for the deficiency of the endogenous IL-36 regulator in patients with GPP. Imsidolimab has successfully concluded its development program ...

While vaccine sales dropped, GSK raised its revenue guidance for 2031 with speciality medicines expected to drive that growth ...

GSK Plc's U.S.-listed shares surged Wednesday after the pharmaceutical firm boosted its long-term outlook and launched a $2.5 billion stock buyback on the back of optimism about sales of its new drugs ...

GSK delivered a mixed fourth-quarter report Wednesday, but GSK stock surged on its long-term outlook for more than $50 ...

Shares of GSK Plc. were gaining around 6 percent on the London Stock Exchange, as well as in the pre-market activity on the NYSE, ...